Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ventilator Associated Bacterial Pneumonia (VABP)”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)Looking for participantsNCT07327619
What this trial is testing

Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Who this might be right for
Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
Qilu Pharmaceutical Co., Ltd. 420
Not applicableStudy completedNCT02420366
What this trial is testing

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Who this might be right for
Urinary Tract Infection, ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+2 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 257
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)Study completedNCT05204563
What this trial is testing

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Who this might be right for
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc. 450
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Large-scale testing (Phase 3)UnknownNCT01865266
What this trial is testing

The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia

Who this might be right for
Ventilator-associated Bacterial PneumoniaMechanical Ventilation Complication
Shanghai Minhang Central Hospital 60
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307
What this trial is testing

Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
BioVersys AG
Large-scale testing (Phase 3)Study completedNCT01292031
What this trial is testing

Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)

Who this might be right for
Ventilator-associated Bacterial Pneumonia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 232
Testing effectiveness (Phase 2)Looking for participantsNCT06087536
What this trial is testing

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Who this might be right for
Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia
Omnix Medical Ltd 54
Large-scale testing (Phase 3)Ended earlyNCT03409679
What this trial is testing

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Who this might be right for
Pneumonia
Polyphor Ltd. 41
Not applicableStudy completedNCT02689531
What this trial is testing

CTTI Risk Factors for HABP/VABP Study

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia, Hospital-Acquired
Duke University 7,530
Testing effectiveness (Phase 2)Ended earlyNCT01570192
What this trial is testing

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Who this might be right for
Bacterial Pneumonia
University of Florida 43
Post-approval studies (Phase 4)Looking for participantsNCT07004049
What this trial is testing

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Who this might be right for
Bloodstream InfectionVentilator Associated Bacterial PneumoniaHospital Acquired Bacterial Pneumonia+2 more
National University of Singapore 600
Not applicableLooking for participantsNCT06746883
What this trial is testing

Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 100
Large-scale testing (Phase 3)Study completedNCT01970371
What this trial is testing

Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

Who this might be right for
Bloodstream Infections (BSI) Due to CREHospital-Acquired Bacterial Pneumonia (HABP) Due to CREVentilator-Associated Bacterial Pneumonia (VABP) Due to CRE+2 more
Achaogen, Inc. 69
Testing effectiveness (Phase 2)Looking for participantsNCT07512596
What this trial is testing

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Who this might be right for
Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Testing effectiveness (Phase 2)Looking for participantsNCT07759934
What this trial is testing

ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Who this might be right for
Ventilator-associated Bacterial Pneumonia (VABP)Hospital-acquired Bacterial Pneumonia (HABP)
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 60
Next Page
120